Back to UBS Group AG UBS Group AG

NERVNERV
Showing 8 of 26 quarters

Position history for UBS Group AGUBS Group AG's holdings in MINERVA NEUROSCIENCES INC

UBS Group AG holds 67,570 shares of NERV (MINERVA NEUROSCIENCES INC), worth $407,109 as of 2026-Q1. The position was increased (+3639.3% shares). NERV represents 0.0% of UBS Group AG's portfolio.

Current Value

$407,109

Current Shares

67,570

Total Value Change

+$407,077

Total Shares Change

+67,560

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
67,570
+3639.3%
$407,1090.0%$6.86
38
2025-Q4
Increased
1,807
+180x
$7,2640.0%$4.06
18
2025-Q3
Decreased
10
-98.9%
$210.0%$2.10
0
2025-Q2
Decreased
875
-46.0%
$1,5050.0%$1.78
0
2025-Q1
Increased
1,621
+134x
$2,7560.0%$1.81
14
2024-Q4
Decreased
12
-99.9%
$270.0%$2.29
0
2024-Q3
Increased
10,552
+1054x
$28,1740.0%$2.70
21
2024-Q2
Unchanged
10
0.0%
$320.0%$3.19
0

Other major holders of NERV: FEDERATED HERMES, INC.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used